-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down to $1.86
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down to $1.86
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) shares gapped down prior to trading on Monday . The stock had previously closed at $1.86, but opened at $1.77. Bionano Genomics shares last traded at $1.88, with a volume of 41,758 shares traded.
Analyst Upgrades and Downgrades
Separately, Oppenheimer reaffirmed an "outperform" rating and set a $12.00 target price on shares of Bionano Genomics in a research note on Monday, July 18th.
Get Bionano Genomics alerts:Bionano Genomics Price Performance
The business's 50 day simple moving average is $2.37 and its 200-day simple moving average is $1.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.75.
Bionano Genomics (NASDAQ:BNGO – Get Rating) last released its quarterly earnings data on Thursday, August 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). Bionano Genomics had a negative net margin of 453.68% and a negative return on equity of 33.21%. The firm had revenue of $6.67 million for the quarter, compared to analyst estimates of $6.20 million. Equities analysts forecast that Bionano Genomics, Inc. will post -0.44 EPS for the current fiscal year.Insider Activity at Bionano Genomics
In related news, Director Yvonne Linney sold 20,000 shares of Bionano Genomics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $3.62, for a total value of $72,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Blackston Financial Advisory Group LLC bought a new stake in Bionano Genomics in the 4th quarter valued at $30,000. Merit Financial Group LLC bought a new position in Bionano Genomics during the first quarter worth about $28,000. Freestone Capital Holdings LLC acquired a new stake in Bionano Genomics during the first quarter valued at approximately $29,000. Magnus Financial Group LLC bought a new stake in shares of Bionano Genomics in the 1st quarter valued at approximately $33,000. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Bionano Genomics in the 1st quarter worth approximately $33,000. 28.44% of the stock is owned by institutional investors.
Bionano Genomics Company Profile
(Get Rating)
Bionano Genomics, Inc provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
Further Reading
- Get a free copy of the StockNews.com research report on Bionano Genomics (BNGO)
- Three Consumer Stocks That Could Outperform In Q4
- Comcast is an Asset Bonanza Priced Cheap
- Will Synthetic Biology Firm Amyris Post Net Income In 2024?
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) shares gapped down prior to trading on Monday . The stock had previously closed at $1.86, but opened at $1.77. Bionano Genomics shares last traded at $1.88, with a volume of 41,758 shares traded.
生物納米基因組公司(納斯達克代碼：BNGO-GET Rating)的股價週一開盤前大幅下跌。該股此前收盤報1.86美元，開盤報1.77美元。生物納米基因組公司的股票最新報1.88美元，總成交量為41,758股。
Analyst Upgrades and Downgrades
分析師升級和下調評級
Separately, Oppenheimer reaffirmed an "outperform" rating and set a $12.00 target price on shares of Bionano Genomics in a research note on Monday, July 18th.
另外，奧本海默在7月18日(星期一)的一份研究報告中重申了對Bionano Genonics的評級，併為其股票設定了12.00美元的目標價。
Bionano Genomics Price Performance
生物納米基因組學性價比
The business's 50 day simple moving average is $2.37 and its 200-day simple moving average is $1.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.75.
該業務的50日簡單移動均線切入位在2.37美元，200日簡單移動均線切入位在1.99美元。該公司的負債權益比率為0.01，速動比率為7.01，流動比率為7.75。
Insider Activity at Bionano Genomics
Bionano基因組公司的內部活動
In related news, Director Yvonne Linney sold 20,000 shares of Bionano Genomics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $3.62, for a total value of $72,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.
在相關新聞中，董事伊馮·林尼在8月15日(星期一)的一筆交易中出售了20,000股Bionano基因公司的股票。這些股票的平均價格為3.62美元，總價值為72,400.00美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過此超鏈接。1.20%的股份目前由公司內部人士持有。
Institutional Inflows and Outflows
機構資金流入和流出
Institutional investors have recently made changes to their positions in the stock. Blackston Financial Advisory Group LLC bought a new stake in Bionano Genomics in the 4th quarter valued at $30,000. Merit Financial Group LLC bought a new position in Bionano Genomics during the first quarter worth about $28,000. Freestone Capital Holdings LLC acquired a new stake in Bionano Genomics during the first quarter valued at approximately $29,000. Magnus Financial Group LLC bought a new stake in shares of Bionano Genomics in the 1st quarter valued at approximately $33,000. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Bionano Genomics in the 1st quarter worth approximately $33,000. 28.44% of the stock is owned by institutional investors.
機構投資者最近改變了他們在該股的頭寸。Blackston Financial Consulting Group LLC在第四季度以3萬美元的價格購買了Bionano基因組公司的新股份。優點金融集團有限責任公司在第一季度購買了Bionano基因組公司的一個新頭寸，價值約28,000美元。Frestone Capital Holdings LLC在第一季度收購了Bionano基因組公司的新股份，價值約2.9萬美元。Magnus Financial Group LLC在第一季度購買了Bionano Genology的新股份，價值約33,000美元。最後，資源投資顧問有限責任公司。在第一季度收購了Bionano基因組公司的新股票，價值約33,000美元。28.44%的股份由機構投資者持有。
Bionano Genomics Company Profile
生物納米基因組公司簡介
(Get Rating)
(獲取評級)
Bionano Genomics, Inc provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
生物納米基因組公司提供基因組分析軟件解決方案。它提供了用於通過光學基因組圖譜進行結構變異分析的樣本到結果的解決方案，用於基因組分析和了解遺傳變異和功能；SAHERR儀器，一個單分子成像儀；SETRUR芯片，一個包裝用於DNA線性化的納米通道陣列的消耗品；以及Bionano製備試劑盒和DNA標記試劑盒，它提供了提取和標記超高分子量的試劑和協議。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Bionano Genomics (BNGO)
- Three Consumer Stocks That Could Outperform In Q4
- Comcast is an Asset Bonanza Priced Cheap
- Will Synthetic Biology Firm Amyris Post Net Income In 2024?
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- 免費獲取StockNews.com關於Bionano基因組學的研究報告(BNGO)
- 三隻可能在第四季度表現優異的消費類股
- 康卡斯特是廉價的資產財源
- 合成生物學公司Amyris將在2024年實現淨收益嗎？
- 卡特彼勒能否在下跌的市場中走得更高？
- Dave&Buster‘s能免受高通脹和低支出的影響嗎？
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.
獲得Bionano基因組學日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Bionano Genonics和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧